Samsung Biologics plans to add mRNA vaccine production line in Seoul
The new move will allow Samsung Biologics to provide end-to-end mRNA vaccine manufacturing services from bulk drug substance…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jun 21
The new move will allow Samsung Biologics to provide end-to-end mRNA vaccine manufacturing services from bulk drug substance…
24 May 21
Equipped with advanced production lines, Samsung Biologics' facilities will support the production of hundreds of millions of doses…
20 May 21
The new cGMP facility will be designed to provide an end-to-end solution to advance cell therapy development and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
07 May 21
The expansion of the manufacturing capacity will help Lonza to deliver contract manufacturing services that will meet the…
28 Apr 21
The company is also committed to donating more than $5m in supplies and equipment to support the pandemic…
27 Apr 21
Sanofi to dedicate its site in Ridgefield, New Jersey to perform fill and finish operations for up to…
23 Apr 21
The new facility will feature advanced technologies, the latest manufacturing equipment and advanced digital systems to deliver critical…
22 Apr 21
J.POD 2 EU marks Evotec’s second cGMP biomanufacturing facility and will be the first commercial biomanufacturing facility in…
16 Apr 21
Novartis will dedicate its large-scale biologics facility in Singapore for the production of API of Roche’s Actemra/RoActemra
07 Apr 21
Catalent will dedicate a new high-speed filling line at the Bloomington site to manufacture Moderna’s Covid-19 vaccine through…